Trades on 3 secondary markets

Neuron23

Neuron23 is a clinical-stage precision-medicine biotechnology company developing genetically targeted small-molecule therapies for neurological and immunological diseases, with a lead precision-medicine program focused on Parkinson's disease. It combines machine-learning-driven genetic biomarker dis

minimal 6.8 / 100 0 APIs View provider profile →
CompanyHealth TechBiotechnologyPrecision MedicineNeurosciencePharmaceuticals

Neuron23 is an API provider whose private shares are listed on 3 secondary markets: Forge Global, EquityZen, Nasdaq Private Market.

Where It Trades

F Forge Global View listing → EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.